
You can review our most frequently asked questions, and see if your enquiry is already answered.
The decisions around which colours to use on different products packaged in our Teva 360 packaging are made using a variety of information, including data showing the likelihood of medicines being prescribed together, or proximity of the products on an alphabetised shelf.
You can discuss this further with your Teva Sales Manager.
See Our packaging for more information, and to use our interactive Teva 360 packaging viewer.
Our SmPCs and PILs are available to download in our Product area.
If the SmPC or PIL you require isn't available, please contact us on 0207 540 7117 or via email medinfo@tevauk.com .
Teva UK Limited is committed to ensuring continued accessibility of our medicines to patients. To ensure Dopacard remains available in the UK, a supply of our product has been imported from France with government approval, following their standard process SI2005/2789: “Notification for the import of unlicensed medicines”.
This temporary packaging change is due to a manufacturing delay. Copies of the SPC and PIL are also available in English to download from our products area.
We apologise for any inconvenience this situation may cause you. We anticipate that normal UK supplies for Dopacard will resume from November 2012.
In the meantime, if you have any comments or queries, please contact Medical Information on 0207 540 7117 or e-mail medinfo@tevauk.com.

To access this section of the Teva UK Limited website you need to be a member of the healthcare profession
because the materials included in this area of our website are specifically prepared for that audience
only.
To understand why that is - please visit: Working in a regulated environment
Please click on the appropriate button below to confirm that you are healthcare professional.
If you are not a healthcare professional, you will be taken to an area of the website that is appropriate
for you.